Sort
64,565 grants matching “drug discovery”
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$787,902Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2024 · CA
Trial of Metformin for TB/HIV Host-directed Therapy
$787,888Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · U01 · FY2020 · AI
Development of a Bioengineered Heparin from a Non-Animal Source
$787,839Robert J Linhardt · Rensselaer Polytechnic Institute · R01 · FY2012 · HL
Geisinger eGenonic Medicine (GeM) Program
$787,777David J. Carey · Geisinger Clinic · U01 · FY2012 · HG
Novel DFG out inhibitors of Abl-kinases to treat PML
$787,776Milton H. Werner · Inhibikase Therapeutics · R44 · FY2016 · AI
The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model
$787,748Peter W Kalivas · Medical University Of South Carolina · U01 · FY2018 · DA
Rapid Kinase Profiling with Luminescent Reporters
$787,730Reena Zutshi · Luceome Biotechnologies, Llc · R44 · FY2012 · GM
Developing novel inhibitors of the gut microbiome to modulate drug metabolism
$787,689Bret David Wallace · Symberix, Inc. · R44 · FY2021 · TR
SENIOR ADMINISTRATIVE ASSISTANT 3THE PURPOSE OF MODIFICATION 0005 IS TO CORRECT
$787,662 · N02 · FY2013 · DA
Developing a Suite of Targeted Anticancer Drugs
$787,640Paul Hergenrother · University Of Illinois At Urbana-Champaign · R35 · FY2025 · CA
Drug discovery of COMT inhibitors to treat cognitive deficits in schizophrenia
$787,626James Barrow · Lieber Institute, Inc. · R01 · FY2018 · MH
The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort
$787,606Michael D Greicius · Stanford University · R01 · FY2020 · AG
Human Isogenic Organoid Models of Genetic Forms of Autism to Identify Convergent and Divergent Pathomechanisms in Autism
$787,592Eugene Wei-Ming Yeo · University Of California, San Diego · R01 · FY2024 · MH
The Penn Center For Molecular Discovery
$787,500Scott L Diamond · University Of Pennsylvania · U54 · FY2008 · HG
Cellular logic of phenotype
$787,500James H Eberwine · University Of Pennsylvania · DP1 · FY2008 · OD
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$787,500Kory J. Lavine · Washington University · R35 · FY2022 · HL
Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic
$787,474Jeffrey Nicholas Johnston · Vanderbilt University · R01 · FY2020 · HL
Bay Area Cancer Target Discovery and Development Network
$787,464Frank Patrick McCormick · University Of California, San Francisco · U01 · FY2014 · CA
Supporting Biomedical Discovery with the ROBOKOP Graph Knowledgebase.
$787,035Alexander Tropsha · Univ Of North Carolina Chapel Hill · U24 · FY2024 · ES
Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein.
$787,023Timothy McKinsey · University Of Colorado Denver · R01 · FY2019 · HL
Optimization of Drug-like Properties of CRFBP-CRF2 Negative Allosteric Modulators for Alcohol Use Disorder
$786,961Douglas J Sheffler · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2025 · AA
Clinical Protocol and Data Management/Clinical Trials Office (Core-015)
$786,715Vicki Leigh Keedy · Vanderbilt University Medical Center · P30 · FY2018 · CA
Clinical Protocol and Data Management/Clinical Trials Office (Core-015)
$786,715Vicki Leigh Keedy · Vanderbilt University Medical Center · P30 · FY2017 · CA
Mechanisms of Maladaptation in Heart Failure
$786,675Howard A Rockman · Duke University · R01 · FY2019 · HL
The Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort
$786,654Michael D Greicius · Stanford University · R01 · FY2019 · AG